Clinical trials
Active, not recruiting Phase 2 Cognitive Dysfunction trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2017 | 1 |
| 2019 | 2 |
| 2021 | 7 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acumen Pharmaceuticals | 1 |
| Akira Sekikawa | 1 |
| Aptinyx | 1 |
| Arctic Therapeutics | 1 |
| Columbia University | 1 |
| Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 1 |
| Gregory Jicha, MD, PhD | 1 |
| High Point University | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| Imperial College London | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cognitive Dysfunction | 19 |
| Alzheimer Disease | 7 |
| Dementia | 4 |
| Inflammation | 2 |
| Atherosclerosis | 1 |
| Carotid Stenosis | 1 |
| Hippocampal Sclerosis | 1 |
| Lewy Body Disease | 1 |
| Memory Disorders | 1 |
| Parkinson Disease | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.